Inc. has seen its stock tumble to a 52-week low, touching down at $1.12. With a current market capitalization of just $93 million, the company maintains a strong liquidity position with a current ...

Biotech stocks are revolutionizing healthcare with breakthrough innovations, leading the charge in precision therapies and ...

AbbVie ( ABBV 0.64%) is a leader in biopharmaceuticals with a product portfolio spanning multiple therapeutic areas, ...

Anthos Therapeutics was set up by Blackstone Life Sciences after it licensed abelacimab drug from Novartis in 2019 ...

The trial will evaluate the safety and effectiveness of a next-generation vaccine administered through a nasal spray or ...

Despite continued underperformance in 2024, the biotech sector enters 2025 with a brighter outlook driven by groundbreaking ...

Robert F. Kennedy Jr. may soon be America's top pharmaceutical regulator. That is cause for concern in Seattle’s biotech ...

It’s widely recognized that health care is a growing expense for many Americans. However, what health care companies do with their profits — some made through government programs such as Medicare — ...

Purple Biotech (PPBT) announced that it has entered into a Research Collaboration Agreement with the Icahn School of Medicine at Mount Sinai in New York, NY, to explore the immunoregulation of NK ...

Collaboration to explore the immunoregulation of NK and T cells within the tumor microenvironment (TME) by CAPTN-3, with the goal of enhancing ...